Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
102 hedge funds and large institutions have $863M invested in Portola Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 44 increasing their positions, 18 reducing their positions, and 14 closing their positions.
144% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 18
86% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 14
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
11% more funds holding
Funds holding: 92 → 102 (+10)
10% more capital invested
Capital invested by funds: $787M → $863M (+$75.5M)
6.5% more ownership
Funds ownership: 74.52% → 81.01% (+6.5%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $31K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$43.4M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$30.7M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$12.1M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$11.9M |
| 5 |
JP Morgan Chase
New York
|
+$8.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$32.6M |
| 2 |
SG Americas Securities
New York
|
-$25.2M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$12.1M |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$10.3M |
| 5 |
Jennison Associates
New York
|
-$9.44M |
PTLA Hedge Fund Activity: Q1 2014 in Review
102 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q1 2014, worth a combined $863M — up 9.6% from $787M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new PTLA positions and 14 closed out — a net gain of 12 holders — while 44 added to existing stakes and 18 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $43.4M. The largest seller was MPM Asset Management, cutting an estimated $32.6M.
- 102 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q1 2014, up from 92 in Q4 2013.
- Funds reported $863M of Portola Pharmaceuticals, Inc. stock for Q1 2014, up 9.6% quarter-over-quarter.
- 26 funds opened new Portola Pharmaceuticals, Inc. positions in Q1 2014 and 14 closed out, a net change of +12 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q1 2014 was Fidelity Investments, an estimated $43.4M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q1 2014 was MPM Asset Management, an estimated $32.6M sold.
Based on aggregated 13F filings for Q1 2014.